Hancock Jaffe Laboratories- Warrants (30/05/2023) Receivables

Hancock Jaffe Laboratories- Warrants (30/05/2023) (HJLIW) currently reports a receivables of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Hancock Jaffe Laboratories- Warrants (30/05/2023)'s receivables history and peer comparisons.

Hancock Jaffe Laboratories- Warrants (30/05/2023)'s receivables changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hancock Jaffe Laboratories- Warrants (30/05/2023) reported $0 in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hancock Jaffe Laboratories- Warrants (30/05/2023), and consider following HJLIW for alerts when major investors trade the stock.

Hancock Jaffe Laboratories- Warrants (30/05/2023) is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HJLIW with unrelated industries.